Literature DB >> 20799094

Newly identified CpG ODNs, M5-30 and M6-395, stimulate mouse immune cells to secrete TNF-alpha and enhance Th1-mediated immunity.

Sun-Shim Choi1, Eunkyung Chung, Yu-Jin Jung.   

Abstract

Bacterial CpG motifs are known to induce both innate and adaptive immunity in infected hosts via toll-like receptor 9 (TLR9). Because small oligonucleotides (ODNs) mimicking bacterial CpG motifs are easily synthesized, they have found use as immunomodulatory agents in a number of disease models. We have developed a novel bioinformatics approach to identify effective CpG ODN sequences and evaluate their function as TLR9 ligands in a murine system. Among the CpG ODNs we identified, M5-30 and M6-395 showed significant ability to stimulate TNF-alpha and IFN-gamma production in a mouse macrophage cell line and mouse splenocytes, respectively. We also found that these CpG ODNs activated cells through the canonical NF-kappa B signaling pathway. Moreover, both CpG ODNs were able to induce Th1-mediated immunity in Mycobacterium tuberculosis (Mtb)-infected mice. Our results demonstrate that M5-30 and M6-395 function as TLR9-specific ligands, making them useful in the study of TLR9 functionality and signaling in mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20799094     DOI: 10.1007/s12275-010-0053-6

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  27 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 2.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

3.  TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function.

Authors:  Wei Jiang; Michael M Lederman; Clifford V Harding; Benigno Rodriguez; Richard J Mohner; Scott F Sieg
Journal:  Eur J Immunol       Date:  2007-08       Impact factor: 5.532

4.  A comparative analysis of cytokine responses, cell surface marker expression and MAPKs in DCs matured with LPS compared with a panel of TLR ligands.

Authors:  David Dowling; Clare M Hamilton; Sandra M O'Neill
Journal:  Cytokine       Date:  2008-01-24       Impact factor: 3.861

5.  The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets.

Authors:  Hiroaki Hemmi; Tsuneyasu Kaisho; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

6.  Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells.

Authors:  Antje Heit; Tobias Maurer; Hubertus Hochrein; Stefan Bauer; Katharina M Huster; Dirk H Busch; Hermann Wagner
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

7.  Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.

Authors:  A Krug; A Towarowski; S Britsch; S Rothenfusser; V Hornung; R Bals; T Giese; H Engelmann; S Endres; A M Krieg; G Hartmann
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

8.  CpG DNA induced IL-12 p40 gene activation is independent of STAT1 activation or production of interferon consensus sequence binding protein.

Authors:  Mary Bradford; Arin J Schroeder; Herbert C Morse; Stefanie N Vogel; John S Cowdery
Journal:  J Biomed Sci       Date:  2002 Nov-Dec       Impact factor: 8.410

9.  CpG oligodeoxynucleotides induce expression of proinflammatory cytokines and chemokines in astrocytes: the role of c-Jun N-terminal kinase in CpG ODN-mediated NF-kappaB activation.

Authors:  Soojin Lee; Jinpyo Hong; Se-Young Choi; Seog Bae Oh; Kyungpyo Park; Joong Soo Kim; Michael Karin; Sung Joong Lee
Journal:  J Neuroimmunol       Date:  2004-08       Impact factor: 3.478

10.  'Immunization' against airborne tuberculosis by an earlier primary response to a concurrent intravenous infection.

Authors:  Yu-Jin Jung; Ronald LaCourse; Lynn Ryan; Robert J North
Journal:  Immunology       Date:  2008-01-23       Impact factor: 7.397

View more
  5 in total

Review 1.  New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.

Authors:  Majid Faridgohar; Hassan Nikoueinejad
Journal:  Pathog Glob Health       Date:  2017-07-17       Impact factor: 2.894

Review 2.  Injection site reactions after subcutaneous oligonucleotide therapy.

Authors:  Leonie van Meer; Matthijs Moerland; Jolie Gallagher; Martijn B A van Doorn; Errol P Prens; Adam F Cohen; Robert Rissmann; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2016-05-31       Impact factor: 4.335

3.  Antigen-pulsed bone marrow-derived and pulmonary dendritic cells promote Th2 cell responses and immunopathology in lungs during the pathogenesis of murine Mycoplasma pneumonia.

Authors:  Nicole A Dobbs; Xia Zhou; Mark Pulse; Lisa M Hodge; Trenton R Schoeb; Jerry W Simecka
Journal:  J Immunol       Date:  2014-06-27       Impact factor: 5.422

4.  Newly Identified TLR9 Stimulant, M6-395 Is a Potent Polyclonal Activator for Murine B Cells.

Authors:  Mi-Hee Park; Yu-Jin Jung; Pyeung-Hyeun Kim
Journal:  Immune Netw       Date:  2012-02-29       Impact factor: 6.303

5.  Designing and Construction of a Cloning Vector Containing mpt64 Gene of Mycobacterium tuberculosis.

Authors:  Hosna Zare; Ehsan Aryan; Shadi Alami; Atieh Yaghoubi; Roghayeh Teimourpour; Zahra Meshkat
Journal:  Tanaffos       Date:  2018-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.